Seqens Seqens

X

Find Radio Compass News for Ospemifene

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215574

FDA
13 Feb 2024

https://www.prnewswire.com/news-releases/duchesnay-usa-announces-the-launch-of-a-new-osphena-ospemifene-website-300900771.html

PR NEWSWIRE
13 Aug 2019

http://www.shionogi.eu/media/37457/07052013.pdf

PRESS RELEASE
07 May 2017

http://www.shionogi.com/newsroom/article.html#122508

10 Mar 2017

http://www.prnewswire.com/news-releases/duchesnay-expands-its-womens-health-product-portfolio-with-acquisition-of-osphena-from-shionogi-inc-300421928.html

PR NEWSWIRE
10 Mar 2017

http://www.fiercepharma.com/marketing/endocuetics-close-to-a-deal-u-s-marketing-partner-for-treatment-painful-sex-after

Beth Snyder Bulik FIERCE PHARMA
30 Nov 2016

http://www.prnewswire.com/news-releases/shionogi-inc-initiates-phase-3-clinical-study-of-osphena-for-the-treatment-of-postmenopausal-vaginal-dryness-300186501.html

PR NEWS WIRE
02 Dec 2015

http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002780/WC500182778.pdf

EMA
17 Feb 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY